Skip to main content
. 2023 Feb 11;58(4):313–345. doi: 10.1007/s00535-023-01958-z
Statement 1.13: Asymptomatic patients: Those with elevated levels of CRP or FC should be considered for assessment of intestinal inflammation using endoscopic or imaging studies (Evidence level 1a/1b)

Voting agreement rate

45/45 (100%)